Literature DB >> 5913780

Hepatography for detection of small tumor masses in liver: experiences with oily contrast medium.

Y Idezuki, M Sugiura, S Hatano, S Kimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5913780

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  6 in total

1.  Selective segmental hepatic necrosis produced by the Shwartzman mechanism in rabbits.

Authors:  Y Ohno; J Shiga; W Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma.

Authors:  Y Katagiri; K Mabuchi; T Itakura; K Naora; K Iwamoto; Y Nozu; S Hirai; N Ikeda; T Kawai
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology.

Authors:  T Imaeda; Y Yamawaki; M Seki; H Goto; G Iinuma; M Kanematsu; R Mochizuki; H Doi; S Saji; K Shimokawa
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jul-Aug       Impact factor: 2.740

4.  Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.

Authors:  J T Rubin; M T Lotze; D Rosenfelder; A Brumfield; R Howells; R Schwartz; S Sylvestri; J Sammon; K Bron; P Orens
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

5.  Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.

Authors:  M Kanematsu
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

Review 6.  Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.

Authors:  Clifford Akateh; Sylvester M Black; Lanla Conteh; Eric D Miller; Anne Noonan; Eric Elliott; Timothy M Pawlik; Allan Tsung; Jordan M Cloyd
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.